Get the Stockscreener App
7.64
4.02%
-0.33
Anavex Life Sciences Corporation stock is traded at $7.64, with a volume of 259.42K.
It is down -4.02% in the last 24 hours and down -23.19% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$7.97
Open:
$7.9
24h Volume:
259.42K
Relative Volume:
0.24
Market Cap:
$656.23M
Revenue:
-
Net Income/Loss:
$-48.17M
P/E Ratio:
-13.40
EPS:
-0.57
Net Cash Flow:
$-37.10M
1W Performance:
-9.89%
1M Performance:
-23.19%
6M Performance:
-18.27%
1Y Performance:
+11.92%
1-Day Range:
$7.62
$7.938
1-Week Range:
$7.62
$8.45
52-Week Range:
$6.62
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
7.64 | 684.57M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.44 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.71 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.56 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.88 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Will Anavex Life Sciences Corp. (12X1) stock top growth indexes2025 Top Gainers & Free Technical Pattern Based Buy Signals - newser.com
Can Anavex Life Sciences Corp. (12X1) stock deliver double digit returnsWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - newser.com
Anavex Life Sciences (NASDAQ:AVXL) Earns Buy Rating from D. Boral Capital - MarketBeat
Will Anavex Life Sciences Corp. (12X1) stock rise with strong economyDollar Strength & Stepwise Entry and Exit Trade Signals - newser.com
Anavex Life Sciences (AVXL) Price Target Increased by 28.16% to 44.88 - Nasdaq
D. Boral Capital Maintains Anavex Life Sciences (AVXL) Buy Recommendation - Nasdaq
AVXL Stock Price and Chart — NASDAQ:AVXL - TradingView
Anavex Life Sciences announces continued long-term benefit from oral blarcamesine in Alzheimer's disease - MarketScreener
Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Control Group - markets.businessinsider.com
Anavex Life Sciences Reports Significant Cognitive Benefits of Blarcamesine in Alzheimer's Treatment Compared to Control Group - Quiver Quantitative
Why Is Anavex Life Sciences Stock Trading Higher Today?Anavex Life Sciences (NASDAQ:AVXL) - Benzinga
Anavex (NASDAQ: AVXL) announces 77.4 weeks 'time saved' with blarcamesine over 144 weeks - Stock Titan
Can Anavex Life Sciences Corp. stock deliver strong Q4 earningsEarnings Miss & Weekly Breakout Stock Alerts - newser.com
Can Anavex Life Sciences Corp. stock rebound after recent weaknessJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - fcp.pa.gov.br
Published on: 2025-10-28 04:23:07 - fcp.pa.gov.br
Is Anavex Life Sciences Corp. (12X1) stock testing key supportQuarterly Earnings Summary & High Yield Stock Recommendations - newser.com
Can Anavex Life Sciences Corp. stock sustain institutional interest2025 Volatility Report & Reliable Volume Spike Trade Alerts - fcp.pa.gov.br
Is Anavex Life Sciences Corp. stock vulnerable to regulatory risks2025 Market Overview & Safe Entry Momentum Tips - fcp.pa.gov.br
Is Anavex Life Sciences Corp. stock resilient to inflationMarket Activity Report & Weekly Chart Analysis and Guides - newser.com
Backtesting results for Anavex Life Sciences Corp. trading strategiesMarket Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Is Anavex Life Sciences Corp. stock undervalued vs historical averages2025 Price Action Summary & Free Long-Term Investment Growth Plans - newser.com
Real time breakdown of Anavex Life Sciences Corp. stock performanceWeekly Trade Report & Technical Confirmation Trade Alerts - newser.com
Anavex Life Sciences Corp. $AVXL Shares Acquired by 180 Wealth Advisors LLC - MarketBeat
Why millennials buy Anavex Life Sciences Corp. (12X1) stockShort Setup & AI Enhanced Trade Execution Alerts - newser.com
Candlestick signals on Anavex Life Sciences Corp. stock todayPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com
Anavex Life Sciences' (AVXL) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
What analysts say about Anavex Life Sciences Corp stockMarket Correction Analysis & Free Significant Capital Appreciation - earlytimes.in
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 4.9%Should You Sell? - MarketBeat
Jones Trading Downgrades Anavex Life Sciences (NASDAQ:AVXL) to Hold - MarketBeat
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Promising 403% Upside in the Biotechnology Sector - DirectorsTalk Interviews
Anavex Life Sciences (NASDAQ:AVXL) Shares Pass Above 50 Day Moving AverageTime to Sell? - MarketBeat
Jones Trading downgrades Anavex stock to Hold ahead of critical EMA decision - Investing.com UK
How strong is Anavex Life Sciences Corp. stock revenue growthJuly 2025 Catalysts & Reliable Momentum Entry Alerts - newser.com
Visual trend scoring systems applied to Anavex Life Sciences Corp.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Tools to monitor Anavex Life Sciences Corp. recovery probabilityPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Visualizing Anavex Life Sciences Corp. stock with heatmapsJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Heatmap analysis for Anavex Life Sciences Corp. and competitors2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
How Anavex Life Sciences Corp. stock reacts to global recession fearsQuarterly Profit Summary & Safe Swing Trade Setups - Trung tâm Dự báo KTTV quốc gia
Anavex Life Sciences (STU:12X1) Cyclically Adjusted PS Rati - GuruFocus
Will Anavex Life Sciences Corp. (12X1) stock keep high P E multiplesMarket Performance Summary & Precise Buy Zone Identification - nchmf.gov.vn
Can trapped investors hope for a rebound in Anavex Life Sciences Corp.July 2025 PostEarnings & Daily Price Action Insights - newser.com
Aug Weekly: Can Anavex Life Sciences Corp. stock weather global recessionQuarterly Portfolio Report & Fast Gain Stock Tips - Trung tâm Dự báo KTTV quốc gia
Geopolitics Watch: How Anavex Life Sciences Corp. stock valuations compare to rivalsJuly 2025 Retail & Low Drawdown Momentum Ideas - Trung tâm Dự báo KTTV quốc gia
Will Anavex Life Sciences Corp. stock split again soonInflation Watch & Proven Capital Preservation Tips - Trung tâm Dự báo KTTV quốc gia
How Anavex Life Sciences Corp. stock valuations compare to rivalsTreasury Yields & Verified Swing Trading Watchlists - Trung tâm Dự báo KTTV quốc gia
Can machine learning forecast Anavex Life Sciences Corp. recoveryRate Cut & Consistent Return Strategy Ideas - newser.com
Anavex Life Sciences Corp. (AVXL) Stock Analysis: A 281% Potential Upside On The Horizon - DirectorsTalk Interviews
US High Growth Tech Stocks To Watch For Potential Expansion - simplywall.st
Detecting price anomalies in Anavex Life Sciences Corp. with AI2025 Short Interest & Accurate Buy Signal Notifications - newser.com
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):